Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

CRTX

Cortexyme (CRTX)

Cortexyme Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:CRTX
DataHoraFonteTítuloCódigoCompanhia
26/05/202318:51Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CRTXCortexyme Inc
25/05/202317:26Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CRTXCortexyme Inc
14/04/202317:13Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:CRTXCortexyme Inc
14/04/202317:07Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:CRTXCortexyme Inc
05/04/202318:16Edgar (US Regulatory)Securities Registration (section 12(b)) (8-a12b)NASDAQ:CRTXCortexyme Inc
31/03/202317:01Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CRTXCortexyme Inc
15/03/202318:07Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:CRTXCortexyme Inc
13/02/202319:29Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CRTXCortexyme Inc
09/11/202218:26Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CRTXCortexyme Inc
18/12/200916:45PR Newswire (US)Cornerstone Therapeutics to Host Conference Call to Discuss Financial Guidance for 2010NASDAQ:CRTX
20/11/200918:40PR Newswire (US)Cornerstone Therapeutics Provides a Response to FDA Warning Letter on DeconsalNASDAQ:CRTX
16/11/200911:00PR Newswire (US)Cornerstone Therapeutics to Present at the 6th Annual Lazard Capital Markets Healthcare ConferenceNASDAQ:CRTX
13/11/200911:00PR Newswire (US)Cornerstone Therapeutics Appoints General CounselNASDAQ:CRTX
04/11/200910:00PR Newswire (US)Cornerstone Therapeutics Reports Third Quarter 2009 Financial ResultsNASDAQ:CRTX
21/10/200910:00PR Newswire (US)Cornerstone Therapeutics to Host Third Quarter 2009 Conference CallNASDAQ:CRTX
03/09/200909:01PR Newswire (US)Cornerstone Therapeutics Receives Approval to Acquire Commercial Rights to the Antibiotic Factive(R)NASDAQ:CRTX
03/09/200909:00PR Newswire (US)Cornerstone Therapeutics to Present at Two Upcoming Investor ConferencesNASDAQ:CRTX
20/07/200909:00PR Newswire (US)Cornerstone Therapeutics' David Price Named 2009 Chief Financial Officer of the Year by the Triangle Business JournalNASDAQ:CRTX
15/07/200920:04PR Newswire (US)Cornerstone Therapeutics Submits Regulatory Filing for Extended-Release Antitussive ProductNASDAQ:CRTX
08/07/200917:15PR Newswire (US)Cornerstone Therapeutics Inc. Announces Record Date and Meeting Date for Special Meeting of Stockholders for Vote with Respect tNASDAQ:CRTX
12/06/200917:35Dow Jones NewsUPDATE:FDA Updates Singulair Label For Neuropsychiatric EventsNASDAQ:CRTXCornerstone Therapeutics Inc.
12/06/200916:28Dow Jones NewsFDA: Updates Singulair Label For Neuropsychiatric EventsNASDAQ:CRTXCornerstone Therapeutics Inc.
19/05/200917:01PR Newswire (US)Cornerstone Therapeutics Announces Management ChangeNASDAQ:CRTX
07/05/200908:01PR Newswire (US)Cornerstone Therapeutics Announces $70 Million Strategic Transaction With Chiesi Farmaceutici SpANASDAQ:CRTX
07/05/200908:00PR Newswire (US)Cornerstone Therapeutics Reports First Quarter 2009 Financial ResultsNASDAQ:CRTX
27/04/200909:00PR Newswire (US)Cornerstone Therapeutics to Host First Quarter 2009 Conference CallNASDAQ:CRTX
13/01/200920:33Dow Jones NewsUPDATE: Singular, Zyflo Asthma Drug Safety Review ContinuesNASDAQ:CRTXCornerstone Therapeutics Inc.
13/01/200918:34Dow Jones NewsFDA: Singular, Zyflo Asthma Drug Safety Review ContinuesNASDAQ:CRTXCornerstone Therapeutics Inc.
05/11/200811:00PR Newswire (US)Cornerstone Therapeutics Announces New Board of DirectorsNASDAQ:CRTX
01/08/200611:00PR Newswire (US)Critical Therapeutics Files Controlled Release Formulation of ZileutonNASDAQ:CRTX
 Apresentando as notícias mais relevantes sobre:NASDAQ:CRTX